© Copyright GW Pharmaceuticals 2021
This website is intended for healthcare professionals only. If you are not a healthcare professional, please visit www.gwpharm.co.uk
VV-MED-19197
Date of Preparation: March 2021
Browse a library of past webcasts and educational expert-led eLearning videos at your convenience.
Past Webcasts
Epilepsy Focus Webcast: sharing experience with Epidyolex® (cannabidiol) Thursday 10 December 2020
This webcast focused on the diagnosis and management of patients with LGS. The expert faculty discussed:
- The importance of diagnosis in patients with LGS, including syndromic diagnoses
- Cognitive and behavioural problems in patients with LGS receiving GW CBD
- How to best manage polytherapy in patients with LGS receiving GW CBD
- The evolution of LGS and implications for treatment, as well as diagnosis in adult patients
Epilepsy Focus Webcast: sharing experience with Epidyolex® (cannabidiol) Thursday 10 December 2020
Epilepsy Focus Webcast: sharing experience with Epidyolex® (cannabidiol) Wednesday 23 September 2020
During this webcast, the expert faculty discussed:
- When to consider GW CBD
- The importance of diagnosis: LGS in adult patients
- Managing adverse events associated with GW CBD
- Determining the optimal dose of GW CBD
- Initiating GW CBD in patients who have tried or who are currently receiving non-regulatory approved cannabis-based products
- Early versus late intervention with GW CBD
Epilepsy Focus Webcast: sharing experience with Epidyolex® (cannabidiol) Wednesday 23 September 2020
Epilepsy Focus Webcast: sharing experience with Epidyolex® (cannabidiol) Wednesday 2 September 2020
During this webcast, the expert faculty discussed:
- Identifying patients that might benefit from GW CBD
- Reintroducing clobazam in patients who have previously tried and discontinued clobazam
- Polytherapy and monitoring requirements
- Transition from paediatric to adolescent/adult care
- Epilepsy care and implications for GW CBD treatment in the times of COVID-19
Epilepsy Focus Webcast: sharing experience with Epidyolex® (cannabidiol) Wednesday 2 September 2020
Epilepsy Focus Webcast: sharing experience with Epidyolex® (cannabidiol) Thursday 2 July 2020
During this webcast, the expert faculty discussed:
- GW CBD patient profile
- Starting and maintaining patients on GW CBD
- Managing adverse events associated with GW CBD
- GW CBD in patients who have tried or who are currently receiving unlicensed cannabis-based products
Epilepsy Focus Webcast: sharing experience with Epidyolex® (cannabidiol) Thursday 2 July 2020
Epilepsy Focus Webcast: sharing experience with Epidyolex® (cannabidiol) Thursday 4 June 2020
During this webcast, the expert faculty discussed:
- GW CBD patient profile
- Starting and maintaining patients on GW CBD
- Managing adverse events associated with GW CBD
- GW CBD in patients who have tried or who are currently receiving unlicensed cannabis-based products
Epilepsy Focus Webcast: sharing experience with Epidyolex® (cannabidiol) Thursday 4 June 2020
E-Learning videos
Challenges and solutions in managing children with refractory epilepsy (during the COVID-19 pandemic)
Challenges and solutions in managing children with refractory epilepsy
(during the COVID-19 pandemic)
Professor Richard FM Chin talks about the challenges his team faced during the COVID-19 pandemic and solutions they developed to facilitate remote consultations and monitoring, including vCreate, a cloud-based bidirectional video interface.
Challenges and solutions in managing children with refractory epilepsy (during the COVID-19 pandemic)
Cannabinoid science
Nick Jones discusses developments in cannabinoid medical research, regulatory vs non-regulatory approved cannabis-based products, and the molecular pharmacology and proposed mechanism of action of CBD in epilepsy.
Cannabinoid science
Clinical management
Professor Bernhard Steinhoff discusses the journey of patients with LGS and DS from childhood to adulthood, including age-related treatment considerations and challenges for caregivers and neurologists.
Clinical management
Shared clinical experience: introduction
Shared clinical experience: introduction
Shared clinical experience: GW CBD patient profile
Professor Elizabeth Thiele presents the clinical case of a 22-year-old patient that aims to illustrate the GW CBD patient profile.
Shared clinical experience: GW CBD patient profile
Shared clinical experience: starting and maintaining patients on GW CBD (part 1)
Professor Angela Kaindl describes starting and maintaining patients on GW CBD using an illustrative clinical case of a 13-year-old patient.
Shared clinical experience: starting and maintaining patients on GW CBD (part 1)
Shared clinical experience: starting and maintaining patients on GW CBD (part 2)
Professor Selim Benbadis describes the clinical case of a 25-year-old patient to illustrate starting and maintaining patients on GW CBD.
Shared clinical experience: starting and maintaining patients on GW CBD (part 2)
Shared clinical experience: managing adverse events
Professor Elizabeth Thiele presents a clinical case to demonstrate her management of adverse effects including lethargy and elevated liver function tests in a 19-year-old patient receiving GW CBD.
Shared clinical experience: managing adverse events
Shared clinical experience: patients who have tried or are currently receiving non-regulatory approved cannabis-based products
Professor Selim Benbadis discusses how GW CBD might be introduced in a patient who is currently receiving non-regulatory approved cannabis-based products through an illustrative clinical case study of a 7-year-old patient.
Shared clinical experience: patients who have tried or are currently receiving non-regulatory approved cannabis-based products
For more information about Epidyolex®, please refer to the Epidyolex® summary of product characteristics
and/or the Epidyolex® website for UK Healthcare Professionals.
